Barclays Lowers Exelon (NASDAQ:EXC) Price Target to $42.00

Exelon (NASDAQ:EXCGet Free Report) had its target price lowered by stock analysts at Barclays from $44.00 to $42.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s target price indicates a potential upside of 7.03% from the company’s current price.

Other research analysts also recently issued research reports about the company. Evercore ISI raised Exelon from an “in-line” rating to an “outperform” rating and increased their price target for the company from $43.00 to $44.00 in a report on Tuesday. Scotiabank increased their price target on Exelon from $40.00 to $42.00 and gave the company a “sector perform” rating in a report on Thursday, December 12th. Finally, Morgan Stanley reduced their price target on Exelon from $46.00 to $44.00 and set an “equal weight” rating for the company in a report on Friday, November 22nd. Five equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Exelon currently has a consensus rating of “Moderate Buy” and an average target price of $43.13.

Get Our Latest Analysis on Exelon

Exelon Price Performance

Shares of NASDAQ EXC opened at $39.24 on Wednesday. Exelon has a 1-year low of $33.35 and a 1-year high of $41.19. The business has a 50-day moving average of $38.09 and a 200-day moving average of $38.32. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.09 and a quick ratio of 0.97. The company has a market capitalization of $39.43 billion, a price-to-earnings ratio of 16.15, a PEG ratio of 2.69 and a beta of 0.55.

Exelon (NASDAQ:EXCGet Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.71 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.04. The firm had revenue of $6.15 billion during the quarter, compared to the consensus estimate of $5.85 billion. Exelon had a return on equity of 9.47% and a net margin of 10.60%. Exelon’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.67 earnings per share. On average, equities analysts anticipate that Exelon will post 2.46 EPS for the current fiscal year.

Institutional Trading of Exelon

A number of institutional investors and hedge funds have recently made changes to their positions in EXC. American National Bank & Trust raised its position in shares of Exelon by 178.8% during the 3rd quarter. American National Bank & Trust now owns 697 shares of the company’s stock worth $28,000 after purchasing an additional 447 shares during the period. Ashton Thomas Securities LLC acquired a new stake in shares of Exelon during the 3rd quarter worth approximately $32,000. Crews Bank & Trust acquired a new stake in shares of Exelon during the 4th quarter worth approximately $34,000. Versant Capital Management Inc raised its position in shares of Exelon by 56.7% during the 4th quarter. Versant Capital Management Inc now owns 1,047 shares of the company’s stock worth $39,000 after purchasing an additional 379 shares during the period. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in shares of Exelon during the 2nd quarter worth approximately $57,000. 80.92% of the stock is currently owned by institutional investors and hedge funds.

Exelon Company Profile

(Get Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Articles

Analyst Recommendations for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.